Dabrafenib and trametinib-induced hyperglycemia with decreased insulin secretion in a patient with lung adenocarcinoma.

Tafinlar (dabrafenib) - Novartis

Mekinist (trametinib) - Novartis, BeOne Medicines

http://www.ncbi.nlm.nih.gov/pubmed/42694471

Kenta Hara; Kohei Nagano; Masaki Suzuki; Rikiya Watanabe; Saki Morikawa; Takeshi Ohara

Sep 5, 2026